Capital Research Global Investors Trims CONMED Stake to 8.7%

TL;DR

**Capital Research Global Investors cut its CONMED stake to 8.7%, watch for market reaction.**

AI Summary

Capital Research Global Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing its ownership in CONMED Corp. As of December 29, 2023, the firm beneficially owned 2,757,108 shares of CONMED's Common Stock, representing 8.7% of the company. This filing indicates a slight decrease from their previous reported stake, which could signal a shift in their investment strategy for CONMED, potentially impacting investor sentiment.

Why It Matters

This filing shows a significant institutional investor has slightly reduced its stake in CONMED, which could be interpreted as a loss of conviction or a portfolio rebalancing, potentially influencing other investors' decisions.

Risk Assessment

Risk Level: medium — A reduction in ownership by a large institutional investor like Capital Research Global Investors can sometimes signal underlying concerns or a change in outlook, creating uncertainty for other shareholders.

Analyst Insight

Investors should monitor CONMED's stock performance and look for any further institutional ownership changes. While a reduction by a major holder isn't necessarily a sell signal, it warrants deeper investigation into CONMED's fundamentals and future outlook to understand the rationale behind Capital Research Global Investors' decision.

Key Numbers

• 2,757,108 — Shares Beneficially Owned (This is the total number of CONMED Corp. shares Capital Research Global Investors reported owning as of December 29, 2023.)
• 8.7% — Percentage of Class (This represents the percentage of CONMED Corp.'s Common Stock that Capital Research Global Investors beneficially owns, indicating a significant but slightly reduced stake.)

Key Players & Entities

• Capital Research Global Investors (company) — the reporting person and institutional investor
• CONMED Corp. (company) — the issuer of the securities
• 2,757,108 (dollar_amount) — shares beneficially owned by Capital Research Global Investors
• 8.7% (dollar_amount) — percentage of CONMED Corp. common stock owned by Capital Research Global Investors
• December 29, 2023 (date) — the date of the event requiring the filing

Forward-Looking Statements

• CONMED's stock price may experience short-term volatility as investors react to the news of Capital Research Global Investors reducing its stake. (CONMED Corp.) — medium confidence, target: 1 week

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G/A) — 16KB
• 0001422848-24-000064.txt ( ) — 18KB

From the Filing

SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) * CONMED Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 207410101 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 207410101 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors 95-1411037 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 2,757,108 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 2,757,108 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,757,108 Beneficial ownership disclaimed pursuant to Rule 13d-4 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.0% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer CONMED Corp. (b) Address of Issuer's Principal Executive Offices 11311 Concept Boulevard, Largo, FL 33773 Item 2. (a) Name of Person Filing Capital Research Global Investors (b) Address of Principal Business Office or, if None, Residence 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 (c) Citizenship N/A (d) Title of Class of Securities Common Stock (e) CUSIP Number 207410101 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J). Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 2,757,108 ** (b) Percent of Class: 9.0% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 2,757,108 (ii) shared power to vote or to direct the vote 0 (iii) sole power to dispose or to direct the disposition of 2,757,108 (iv) shared power to dispose or to direct the disposition of 0 **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 2,757,108 shares or 9.0% of the 30,752,199 shares believed to be outstanding. Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five p

View Full Filing

View this SC 13G/A filing on SEC EDGAR